Recent Advances in Visual Dysfunction and Ocular Biomarkers in Neurological Disorders. [PDF]
Cheng J +4 more
europepmc +1 more source
Effect of intracerebroventricular administration of alglucosidase alfa in two mouse models of Lafora disease: Relevance for clinical practice. [PDF]
Zafra-Puerta L +7 more
europepmc +1 more source
Discovery and Evaluation of Active Site-Directed, Potent, and Selective Sulfophenyl Acetic Amide-Based Inhibitors for the Laforin Phosphatase. [PDF]
Lin J +15 more
europepmc +1 more source
VAL-1221 for the treatment of patients with Lafora disease: study protocol for a single-arm, open-label clinical trial. [PDF]
Muccioli L +8 more
europepmc +1 more source
Navigating the diagnostic challenges of myoclonus in neurodegenerative disorders: video-EEG/polygraphy, clinical vignettes, and narrative analysis. [PDF]
d'Orsi G +7 more
europepmc +1 more source
Glycophagy: molecular mechanisms, regulatory signals, and disease associations. [PDF]
Chen L, Jiang J, Liu M, Chen L.
europepmc +1 more source
Clinicopathologic Dissociation: Robust Lafora Body Accumulation in Malin KO Mice Without Observable Changes in Home-Cage Behavior. [PDF]
Krishnan V +12 more
europepmc +1 more source
Gene therapy for Lafora disease in the Epm2a<sup>-/-</sup> mouse model. [PDF]
Zafra-Puerta L +10 more
europepmc +1 more source
Neuromuscular junction dysfunction in Lafora disease. [PDF]
Shukla M, Chugh D, Ganesh S.
europepmc +1 more source
Clinical Signs in 166 Beagles with Different Genotypes of Lafora. [PDF]
Flegel T +6 more
europepmc +1 more source

